Navigation Links
Regado Biosciences, Inc. Presents Three Abstracts Pertaining to its Pipeline of Reversible Antithrombotic Agents, Including the Substudy Analyses of its Phase 2b RADAR Trial for REG1, its Lead Product Candidate, at the American Heart Association (AH
Date:11/14/2011

cond product candidate, which consists of a subcutaneously administered formulation of the specific Factor IXa inhibitor, pegnivacogin, (a.k.a. RB006), paired with an IV bolus formulation of its complementary active control agent, anivamersen, (a.k.a. RB007).  REG2 is anticipated to provide a favorable therapeutic profile with a slow onset of action and duration of effect lasting several days, ideally suited for venous thrombosis indications.

"Presenting such positive REG1 and REG2 data to an audience of industry peers at AHA validates the potential of Regado's science and pipeline," said David J. Mazzo, PhD, President and CEO of Regado.  "The RADAR trial results further demonstrate REG1's ability to promote early arterial sheath removal after cardiac catheterization without increasing time to hemostasis.  We believe this data provides additional validation of REG1's favorable profile as the only truly reversible anticoagulant in development."

"REG2 has also demonstrated significant potential for application in venous thrombosis indications, which is a commentary on our strong pipeline," Dr. Mazzo continued.

About Regado Biosciences

Regado Biosciences, Inc. is a private biopharmaceutical company pioneering a new therapeutic technology with the creation and development of proprietary controllable aptamer drug systems.  Each system comprises a nuclease-stabilized RNA aptamer, the therapeutic effect of which can be reversed partially or completely in real time by its specific and complementary oligonucleotide active control agent.  This technology is being applied to injectable antithrombotics (including anticoagulants and antiplatelet agents) in the acute and sub-acute care cardiovascular setting, a multi-billion dollar world-wide market in need of drugs with improved safety profiles and a greater degree of therapeutic control.  The products in Regado's pipeline are designed to act as optimized antithrom
'/>"/>

SOURCE Regado Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Regado Biosciences, Inc. to Present at the Sofinnova Japan Biopharma Partnering Conference in Tokyo, Japan
2. Regado Biosciences to Present at the Annual UBS Global Life Sciences Conference in New York City
3. Regado Biosciences, Inc. Presents Results of the RADAR Phase 2b Clinical Trial of its REG1 Anticoagulation System
4. Regado Biosciences to Present at the Needham & Companys 10th Annual Healthcare Conference in New York City
5. Regado Biosciences, Inc. Announces Presentation of the Results of the RADAR Phase 2b Clinical Trial of Its Anticoagulant System REG1 at the i2 Summit During the American College of Cardiology 2011 60th Annual Scientific Session & Expo in New Orleans
6. Regado Biosciences to Present at the 2011 RBC Capital Markets Healthcare Conference in New York City
7. Regado Biosciences, Inc. Introduces REG3, a Novel Aptamer-Based Inhibitor of Glycoprotein VI and its Matched Active Control Agent, at the American Heart Association (AHA) Scientific Sessions 2010 Meeting
8. Regado Biosciences, Inc. Presents Pharmacokinetic and Pharmacodynamic (PK/PD) Substudy Results From its Phase 2b RADAR Trial at the American Heart Association (AHA) Scientific Sessions 2010 Meeting
9. Regado Biosciences, Inc. Presents Two Abstracts on the Subcutaneous Depot Formulation of Pegnivacogin, a Nuclease-Stabilized RNA Aptamer, Direct Factor IXa Inhibitor and Part of the REG2 Anticoagulant System, at the American Heart Association (AHA)
10. Regado Biosciences to Present at the IMPACT 2010 Conference in Philadelphia, Pennsylvania
11. Regado Biosciences, Inc. Presents the First-In-Human Clinical Experience with REG2 at the American College of Chest Physicians (ACCP) Coagulation and Heart Disease Sessions in Vancouver, BC, Canada on November 2, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... , Nov. 28, 2014 Alimera Sciences, ... pharmaceutical company that specializes in the research, development ... into a Securities Purchase Agreement with Deerfield Management ... which Alimera will issue shares of preferred stock ... approximately $50.0 million upon the satisfaction of certain ...
(Date:11/28/2014)... HK$,000Six months endedChange %  30 September 201430 September 2013Turnover 546,011 ... Service Income , 384,242 , 339,113 , ... , 41,377 , 49.5 Medical Insurance Administration Service ... 6.4 Medical Devices and Accessories Sales , 94,580 ... , 2,917 , 9,219 , (68.4) ...
(Date:11/27/2014)... Ireland , November 27, 2014 ... Investigational New Drug (IND) Application with the U.S. Food ... in Hovione,s strategy of developing improved drug delivery options ... for minocycline gel, a novel formulation using a new ... one of the most widely prescribed oral antibiotics for ...
Breaking Medicine Technology:Alimera Sciences Announces Agreement with Deerfield Management for $50.0 Million Financing 2Alimera Sciences Announces Agreement with Deerfield Management for $50.0 Million Financing 3Golden Meditech Announces 2014 / 2015 Interim Results 2Golden Meditech Announces 2014 / 2015 Interim Results 3Golden Meditech Announces 2014 / 2015 Interim Results 4Golden Meditech Announces 2014 / 2015 Interim Results 5Golden Meditech Announces 2014 / 2015 Interim Results 6Golden Meditech Announces 2014 / 2015 Interim Results 7Golden Meditech Announces 2014 / 2015 Interim Results 8Hovione Files its First Investigational New Drug Application With the FDA 2
... Holdings Inc. (OTC Bulletin Board: CGNH ) announced ... and Series 2 Class B common stockholders a "Stockholder Questionnaire," ... accurate share count of the Company,s shares currently held in ... If you have not received the Stockholder ...
... 8, 2011 New Mexico Software, Inc. ... announced today enhancements to its technology staff in response ... technology products that support medical IT services and solutions. ... remote healthcare diagnosis that use telemedicine solutions and run ...
Cached Medicine Technology:CardioGenics Requests Stockholders to Participate in Stockholder Questionnaires 2New Mexico Software Enhances Technology Staff to Support Anticipated Sales Growth 2New Mexico Software Enhances Technology Staff to Support Anticipated Sales Growth 3
(Date:11/28/2014)... On Monday, November 24, 2014, just in ... America Eastern Wisconsin with a check for over $11,500. ... portion of proceeds to Feeding America Eastern Wisconsin. Once ... Ways to Save” with Turbana bananas and Fyffes pineapples. ... $4 and Turbana bananas were 29 cents per pound. ...
(Date:11/28/2014)... Dr. Paul Vitenas, one of the most awarded ... Holiday Event for those in the area that would like to ... & Glow will take place on December 11, 2014, from 6:00 ... heart of Houston at 4208 Richmond Ave. , “We want ... will come and celebrate the season with us on December 11, ...
(Date:11/28/2014)... (HealthDay News) -- Planning on seconds at Thanksgiving Day ... clinically known as gastroesophageal reflux disease (GERD) -- a few ... an ear, nose and throat specialist at Lenox Hill Hospital ... manage GERD on Thanksgiving: Pace yourself. ... small meals throughout the day. It,s also a good idea ...
(Date:11/28/2014)... 2014 Earlier in the year, ... hugely popular, 2014 MTV Video Music Awards broadcasted ... ground-breaking celebrity centered television advertisements directed at 11.9 ... were estimated by Entertainment Weekly and ... spotlight on celebrities photographed by paparazzi smoking. In ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 Lice Troopers Lice ... of its in-home head lice service for moms in ... the center of Coral Gables on Pone De-leon Blvd in ... Harbor Islands that service Miami-Dade & Broward. Lice Troopers ... in South Florida which has been treating families for several ...
Breaking Medicine News(10 mins):Health News:Turbana Partners With Sendik's Food Market to Donate $11,500 to Local Hunger-Relief Non-Profit 2Health News:Turbana Partners With Sendik's Food Market to Donate $11,500 to Local Hunger-Relief Non-Profit 3Health News:Cosmetic Surgeon Dr. Paul Vitenas to Host Glitter & Glow Holiday Event 2Health News:Cosmetic Surgeon Dr. Paul Vitenas to Host Glitter & Glow Holiday Event 3Health News:Don't Let Chronic Heartburn Spoil Your Thanksgiving Feast 2Health News:Freedom Laser Therapy Applauds American Legacy’s Creative Advertising Targeting Celebrity Smokers 2Health News:Freedom Laser Therapy Applauds American Legacy’s Creative Advertising Targeting Celebrity Smokers 3Health News:Freedom Laser Therapy Applauds American Legacy’s Creative Advertising Targeting Celebrity Smokers 4Health News:Freedom Laser Therapy Applauds American Legacy’s Creative Advertising Targeting Celebrity Smokers 5Health News:Lice Troopers Lice Removal Service Expands in Miami-Dade 2
... timely reminder of the issues surrounding the binge drinking ... and alcohol, a team lead by Professor Christine Griffin, ... by the Economic and Social Research Council (ESRC) suggests ... on the role of marketing practices in shaping young ...
... Patrick J. McMahon, CPA, was named the Senior Vice ... System. In his new position, McMahon will be part ... Sisters of Charity Health System (SCHS) as it continues ... overall operations of its 20 health, human service and ...
... to more effective ways to control weight , , FRIDAY, Dec. ... activities at suppressing appetite, according to a U.K. study. ... in three types of sessions. In one, they ran for ... hours. In another, they did 90 minutes of weight lifting ...
... DIET Web Site, Features Weight Loss Calculators, Recipes, Customer Rewards Program, ... ... (PRWEB) December 26, 2008 -- Dr. Siegal,s Direct Nutritionals, LLC, the ... DIET® brand weight loss system and hunger-busting diet cookies and diet ...
... would be a real advance since these cells more ... (HealthDay News) -- Researchers say they,ve found a formula ... a mammal, including long-sought rat stem cells. , ... able to mimic human disease in readily produced, genetically ...
... A dentist who owns a successful dental practice and center for ... weight gain during the holiday may contribute to a energy-robbing and ... the neck region, can further complicate breathing while sleeping. , ... ...
Cached Medicine News:Health News:T'is the season to be jolly? 2Health News:Patrick J. McMahon Named Senior Vice President/CFO of Sisters of Charity Health System 2Health News:Patrick J. McMahon Named Senior Vice President/CFO of Sisters of Charity Health System 3Health News:Vigorous Treadmill Workout Curbs Appetite Hormones 2Health News:Dr. Siegal's COOKIE DIET Launches All-New Web Site and Shortens URL to CookieDiet.com 2Health News:Dr. Siegal's COOKIE DIET Launches All-New Web Site and Shortens URL to CookieDiet.com 3Health News:Dr. Siegal's COOKIE DIET Launches All-New Web Site and Shortens URL to CookieDiet.com 4Health News:Scientists May Isolate Stem Cells From Rats, Other Mammals 2Health News:Holiday Weight Gain May Contribute to Sleep Apnea Extra Pounds May Produce Severe Problems for Adults 2
5 inch (12.7 cm), 2 x 5 mm blade....
Nicati foreign body spud....
In reversible handle for removing foreign bodies....
... Focus Night & Day soft contact ... to protect the cornea and to relieve ... or chronic ocular pathologies such as bullous ... corneal dystrophies as well as post-surgical conditions ...
Medicine Products: